Skip to main content
. 2005 Sep 12;102(38):13681–13686. doi: 10.1073/pnas.0506595102

Table 1. Plasma levels of lipid, NO products, and cGMP.

Gp1-HCD Gp2-Arg Gp3-Cit Gp4-Arg + Cit Gp5-Vit Gp6-Vit + Arg Gp7-Mix
T.Chol., mg/dl 1,758 ± 162 1,584 ± 104 1,460 ± 210 1,350 ± 178 1,473 ± 171 1,662 ± 162 1,257 ± 172
Triglycerides, mg/dl 104.2 ± 7.1 120.7 ± 10.5 89.8 ± 4.4 88.8 ± 4.5 98.4 ± 7.1 120.5 ± 8.3 72.3 ± 6.9
HDL-C, mg/dl 29.1 ± 4.8 29.4 ± 3.3 26.0 ± 3.2 34.4 ± 4.1 33.5 ± 5.3 33.9 ± 4.5 35.8 ± 4.1
NO2 + NO3, nM 25.1 ± 2.6 27.3 ± 4.1 25.2 ± 4.0 35.1 ± 5.2* 17.2 ± 3.6 26.8 ± 1.8 29.1 ± 2.1*
cGMP, pg/ml 19.1 ± 3.3 18.9 ± 2.8 32.3 ± 3.7 36.7 ± 5.2* 19.3 ± 4.5 32.9 ± 6.3 41.0 ± 6.1*
Body weight, kg 3.12 ± 0.31 2.96 ± 0.40 3.11 ± 0.31 3.02 ± 0.21 3.23 ± 0.34 2.97 ± 0.23 3.02 ± 0.32

Refer to Materials and Methods for the definitions of the treatment groups. Data are expressed as the mean ± SEM from six rabbits per group. T. Chol, total cholesterol; HDL-C, high-density lipoprotein-cholesterol.

*

Significant difference (P < 0.05) vs. GpI-HCD.